MICAELA WOLFE: Open Payments
NPI 1619520764 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,284 in 105 payments from 16 companies in 2025. Trend: 2023 $1,358 · 2024 $1,785 · 2025 $2,284
Food & beverage: $2,186Education: $98
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $406 |
| ABBVIE INC. | 20 | $273 |
| UCB, Inc. | 11 | $256 |
| Incyte Corporation | 7 | $216 |
| GENZYME CORPORATION | 8 | $196 |
| Lilly USA, LLC | 9 | $166 |
| Regeneron Healthcare Solutions, Inc. | 7 | $160 |
| Galderma Laboratories, L.P. | 4 | $152 |
| Organon LLC | 9 | $120 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $89 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, OPZELURA, NEMLUVIO, EBGLYSS, ILUMYA.
Industry payments across FL — which companies pay providers there.
